Woodle ES - Search Results

1

T-cell infiltrate intensity is associated with delayed response to treatment in late acute cellular rejection in pediatric liver transplant recipients.

Peters AL, Rogers M, Begum G, Sun Q, Fei L, Leino D, Hildeman D, Woodle ES. Peters AL, et al. Among authors: woodle es. Pediatr Transplant. 2023 May;27(3):e14475. doi: 10.1111/petr.14475. Epub 2023 Jan 23. Pediatr Transplant. 2023. PMID: 36691289 Free PMC article.

2

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Tevar A, Woodle ES. Everly MJ, et al. Among authors: woodle es. Transplantation. 2008 Dec 27;86(12):1754-61. doi: 10.1097/TP.0b013e318190af83. Transplantation. 2008. PMID: 19104417

3

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.

Miao Y, Everly JJ, Gross TG, Tevar AD, First MR, Alloway RR, Woodle ES. Miao Y, et al. Among authors: woodle es. Transplantation. 2009 May 15;87(9):1347-59. doi: 10.1097/TP.0b013e3181a238f6. Transplantation. 2009. PMID: 19424035

4

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.

Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES. Walsh RC, et al. Among authors: woodle es. Transplantation. 2010 Feb 15;89(3):277-84. doi: 10.1097/TP.0b013e3181c6ff8d. Transplantation. 2010. PMID: 20145517

5

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.

Walsh RC, Brailey P, Girnita A, Alloway RR, Shields AR, Wall GE, Sadaka BH, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy-Chaudhury P, Woodle ES. Walsh RC, et al. Among authors: woodle es. Transplantation. 2011 Jun 15;91(11):1218-26. doi: 10.1097/TP.0b013e318218e901. Transplantation. 2011. PMID: 21617586

6

Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients.

Schmidt N, Alloway RR, Walsh RC, Sadaka B, Shields AR, Girnita AL, Hanseman DJ, Woodle ES. Schmidt N, et al. Among authors: woodle es. Transplantation. 2012 Aug 27;94(4):352-61. doi: 10.1097/TP.0b013e318257acf6. Transplantation. 2012. PMID: 22836132

7

A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.

Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES. Sadaka B, et al. Among authors: woodle es. Transplantation. 2015 Aug;99(8):1691-9. doi: 10.1097/TP.0000000000000694. Transplantation. 2015. PMID: 25803498

8

Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival.

Krisl JC, Alloway RR, Shield AR, Govil A, Mogilishetty G, Cardi M, Diwan T, Abu Jawdeh BG, Girnita A, Witte D, Woodle ES. Krisl JC, et al. Among authors: woodle es. Transplantation. 2015 Oct;99(10):2167-73. doi: 10.1097/TP.0000000000000706. Transplantation. 2015. PMID: 25856409

9

The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network. Arazi A, et al. Among authors: woodle es. Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. Nat Immunol. 2019. PMID: 31209404 Free PMC article.

10

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network. Arazi A, et al. Among authors: woodle es. Nat Immunol. 2019 Oct;20(10):1404. doi: 10.1038/s41590-019-0473-3. Nat Immunol. 2019. PMID: 31409923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters